These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28861639)

  • 1. Repositioning of proton pump inhibitors in cancer therapy.
    Lu ZN; Tian B; Guo XL
    Cancer Chemother Pharmacol; 2017 Nov; 80(5):925-937. PubMed ID: 28861639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
    Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
    Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism.
    Fais S
    J Intern Med; 2010 May; 267(5):515-25. PubMed ID: 20433578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug repurposing for anticancer therapies. A lesson from proton pump inhibitors.
    Spugnini EP; Fais S
    Expert Opin Ther Pat; 2020 Jan; 30(1):15-25. PubMed ID: 31847622
    [No Abstract]   [Full Text] [Related]  

  • 5. Proton pump inhibitors may reduce tumour resistance.
    De Milito A; Fais S
    Expert Opin Pharmacother; 2005 Jun; 6(7):1049-54. PubMed ID: 15957961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor acidity, chemoresistance and proton pump inhibitors.
    De Milito A; Fais S
    Future Oncol; 2005 Dec; 1(6):779-86. PubMed ID: 16556057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nonmainstream approach against cancer.
    Fais S
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):882-9. PubMed ID: 26972280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds.
    Würth R; Thellung S; Bajetto A; Mazzanti M; Florio T; Barbieri F
    Drug Discov Today; 2016 Jan; 21(1):190-199. PubMed ID: 26456577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Repositioning of Proton Pump Inhibitors for Enhanced Efficacy and Safety of Cancer Chemotherapy.
    Ikemura K; Hiramatsu S; Okuda M
    Front Pharmacol; 2017; 8():911. PubMed ID: 29311921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of proton pump inhibitors in preventing hypergastrinemia-associated carcinogenesis and in antagonizing the trophic effect of gastrin.
    Han YM; Park JM; Kangwan N; Jeong M; Lee S; Cho JY; Ko WJ; Hahm KB
    J Physiol Pharmacol; 2015 Apr; 66(2):159-67. PubMed ID: 25903947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors for the treatment of cancer in companion animals.
    Walsh M; Fais S; Spugnini EP; Harguindey S; Abu Izneid T; Scacco L; Williams P; Allegrucci C; Rauch C; Omran Z
    J Exp Clin Cancer Res; 2015 Sep; 34(1):93. PubMed ID: 26337905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors enhance chemosensitivity, promote apoptosis, and suppress migration of breast cancer cells.
    Ihraiz WG; Ahram M; Bardaweel SK
    Acta Pharm; 2020 Jun; 70(2):179-190. PubMed ID: 31955147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors while belonging to the same family of generic drugs show different anti-tumor effect.
    Lugini L; Federici C; Borghi M; Azzarito T; Marino ML; Cesolini A; Spugnini EP; Fais S
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):538-45. PubMed ID: 26018420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manipulating tumor acidification as a cancer treatment strategy.
    McCarty MF; Whitaker J
    Altern Med Rev; 2010 Sep; 15(3):264-72. PubMed ID: 21155627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repositioning proton pump inhibitors as anticancer drugs by targeting the thioesterase domain of human fatty acid synthase.
    Fako VE; Wu X; Pflug B; Liu JY; Zhang JT
    J Med Chem; 2015 Jan; 58(2):778-84. PubMed ID: 25513712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors.
    Lazzaroni M; Porro GB
    Drugs; 2009; 69(1):51-69. PubMed ID: 19192936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rationale for the use of proton pump inhibitors as antineoplastic agents.
    De Milito A; Marino ML; Fais S
    Curr Pharm Des; 2012; 18(10):1395-406. PubMed ID: 22360553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitor pantoprazole inhibits the proliferation, self‑renewal and chemoresistance of gastric cancer stem cells via the EMT/β‑catenin pathways.
    Feng S; Zheng Z; Feng L; Yang L; Chen Z; Lin Y; Gao Y; Chen Y
    Oncol Rep; 2016 Dec; 36(6):3207-3214. PubMed ID: 27748935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC7901) cells.
    Chen M; Zou X; Luo H; Cao J; Zhang X; Zhang B; Liu W
    Cell Biol Int; 2009 Sep; 33(9):1008-19. PubMed ID: 19501661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitor selectively suppresses proliferation and restores the chemosensitivity of gastric cancer cells by inhibiting STAT3 signaling pathway.
    Huang S; Chen M; Ding X; Zhang X; Zou X
    Int Immunopharmacol; 2013 Nov; 17(3):585-92. PubMed ID: 23973653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.